Carlo Aul

16.0k citations

150 papers · 9.5k indexed · 3 hit papers · h-index 42

Impact in

Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
Genetics top 0.1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

Hematology 123
- Acute Myeloid Leukemia Research 112
- Multiple Myeloma Research and Treatments 22
- Hematopoietic Stem Cell Transplantation 18
Genetics 59
- Myeloproliferative Neoplasms: Diagnosis and Treatment 30
- Chronic Lymphocytic Leukemia Research 26

Co-authors: Aristoteles Giagounidis John M. Bennett Pierre Fenaux Ghulam Mufti Guillermo Sanz David Oscier Christopher Cox Michelle M. LeBeau
Journals: Blood (27 papers)Leukemia Research (22 papers)Annals of Hematology (15 papers)British Journal of Haematology (8 papers)Journal of Clinical Oncology (8 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Carlo Aul

141 papers receiving 9.3k citations

Hit Papers

align trajectories log scale

Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes 2007 · 695 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Journal of Clinical Oncology
2007 Blood
1997 Blood

Peers

Countries citing papers authored by Carlo Aul

Since Specialization

Citations

This map shows the geographic impact of Carlo Aul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Aul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Aul more than expected).

Fields of papers citing papers by Carlo Aul

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlo Aul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Aul. The network helps show where Carlo Aul may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlo Aul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlo Aul Line = papers co-authored together Carlo Aul links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy and Tolerability of High- versus Low-dose Lenalidomide Maintenance Therapy of Multiple Myeloma after Autologous Blood Stem Cell Transplantation Clinical Cancer Research ·Roland Fenk, Aristoteles Giagounidis, Hartmut Goldschmidt, Michael Heinsch, Mathias Rummel, Nicolaus Kröger, R. DeC. Ward, R. Souchuk, Ana Vida, Jamila Thomas, O. Palme, 许广玺, Sebastián Rosenfeld, K. Elias, Carlo Aul, Qasim S. Kadhim, Ariane Dienst, Mustafa Kondakci, Rainer Haas, Guido Kobbe	2020	4
2	Causes of death in 2877 patients with myelodysplastic syndromes Annals of Hematology ·Kathrin Nachtkamp, Sp., Corinna Strupp, Andrea Kündgen, Aristoteles Giagounidis, Carlo Aul, Barbara Hildebrandt, Rainer Haas, Norbert Gattermann, Ulrich Germing	2016	63
3	Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?) Leukemia Research ·John M. Bennett, Heinz Tuechler, Carlo Aul, Corinna Strupp, Ulrich Germing	2016	10
4	Change of prognosis of patients with myelodysplastic syndromes during the last 30 years Leukemia Research ·Judith Neukirchen, Kathrin Nachtkamp, Tri Agusti, Carlo Aul, Aristoteles Giagounidis, Corinna Strupp, Andrea Kuendgen, Guido Kobbe, Rainer Haas, Ulrich Germing	2015	11
5	Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG) Annals of Hematology ·Heiko Becker, Stefan Suciu, Björn Rüter, Uwe Platzbecker, Aristoteles Giagounidis, Dominik Selleslag, Boris Labar, Ulrich Germing, Helmut R. Salih, Petra Muus, Karl-Heinz Pflüger, Anne Hagemeijer, Hans‐Eckart Schaefer, Valeria Fiaccadori, Frédéric Baron, Arnold Ganser, Carlo Aul, Théo de Witte, Pierre W. Wijermans, Michael Lübbert	2015	16
6	Myelodysplastische Syndrome Der Internist ·Carlo Aul, Aristoteles Giagounidis, Ulrich Germing	2010	0
7	Age-Related Risk Profile and Chemotherapy Dose Response in Acute Myeloid Leukemia: A Study by the German Acute Myeloid Leukemia Cooperative Group Journal of Clinical Oncology ·Thomas Büchner, Wolfgang E. Berdel, Claudia Haferlach, Torsten Haferlach, Susanne Schnittger, Carsten Müller‐Tidow, Jan Braess, Karsten Spiekermann, Joachim Kienast, Peter Staib, Andreas Grüneisen, Wolfgang Kern, Albrecht Reichle, Georg Maschmeyer, Carlo Aul, Eva Lengfelder, Maria‐Cristina Sauerland, Achim Heinecke, Bernhard Wörmann, Wolfgang Hiddemann	2008	232
8	Epidemiology, classification and prognosis of adults and children with myelodysplastic syndromes Annals of Hematology ·Ulrich Germing, Carlo Aul, Charlotte M. Niemeyer, Rainer Haas, John M. Bennett	2008	56
9	Therapie der myelodysplastischen Syndrome DMW - Deutsche Medizinische Wochenschrift ·Carlo Aul, A. Heyll	2008	0
10	Intensive Chemotherapy Is Not Recommended for Patients with AML or High-Risk MDS Aged over 60 Years with Complex Karyotype Anomalies. Blood ·Sabine Knipp, Barbara Hildebrandt, Aristoteles Giagounidis, Guido Kobbe, Rainer Haas, Carlo Aul, Norbert Gattermann, Ulrich Germing	2004	6
11	Treatment of relapsed idiopathic thrombocytopenic purpura with the anti‐CD20 monoclonal antibody rituximab: a pilot study European Journal Of Haematology ·Aristoteles Giagounidis, LILY DEMATTOS, Philipp Schneider, Ulrich Germing, D. Söhngen, K. Quabeck, Carlo Aul	2002	98
12	Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups Blood ·T de Witte, Chul Jun Seok, Stefan Suciu, Michel Delforge, M Jotterand-Bellomo, Isabelle Tigaud, J. P. Hansen, Carlo Aul, FagangZhao, Dominik Selleslag, H Schouten, A. Ferrant, Sergio Amadori, Petra Muus, Özlem Anak, F Beeldens, Ramkumar.T.B Ramkumar.T.B, Eva Hellström‐Lindberg, Aloïs Gratwohl, C. Franceschetti	2001	1
13	Epidemiological Features of Myelodysplastic Syndromes: Results From Regional Cancer Surveys and Hospital-Based Statistics International Journal of Hematology ·Carlo Aul, Aristoteles Giagounidis, Ulrich Germing	2001	62
14	Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia Annals of Hematology ·Wolfgang Kern, Carlo Aul, Georg Maschmeyer, R. Kuse, Andrea Kerkhoff, 暢俊添田, Hartmut Eimermacher, Yilin Cindy Xie, Bernhard Wörmann, Thomas Büchner, Wolfgang Hiddemann	1998	18
15	Increasing incidence of myelodysplastic syndromes: Real or fictitious? Leukemia Research ·Carlo Aul, Ulrich Germing, Norbert Gattermann, M A Adler	1998	65
16	Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome Bone Marrow Transplantation ·Volker Runde, T. de Witte, R. Arnold, Aloïs Gratwohl, J. Hermans, Anja van Biezen, Dietger Niederwieser, Myriam Labopin, A. T. Jacovina, Andrea Bacigalupo, N Jacobsen, Per Ljungman, Enric Carreras, HJ Kolb, Carlo Aul, Jane F. Apperley, (unknown)	1998	149
17	Results of conventional-dose cytosine arabinoside and idarubicin in elderly patients with acute myeloid leukemia Annals of Hematology ·A. Heyll, Carlo Aul, Vianinta Geotivanny, Volker Runde, D. Söhngen, Chenxi Zhou, Wit Bryliński, Pingping Tang, M. Burk, M. Winkelmann, F M Poli	1994	14
18	The role of low-dose chemotherapy in myelodysplastic syndromes Leukemia Research ·Carlo Aul, Norbert Gattermann	1992	12
19	Two types of acquired idiopathic sideroblastic anaemia (AISA) British Journal of Haematology ·Norbert Gattermann, Carlo Aul, Wolfgang Schneider	1990	62
20	The role of low-dose cytosine arabinoside and aggressive chemotherapy in advanced myelodysplastic syndromes Cancer ·Carlo Aul, Wolfgang Schneider	1989	57

About Carlo Aul

Carlo Aul is a scholar working on Hematology, Genetics, Emergency Medicine, Pathology and Forensic Medicine and Oncology, having authored 150 papers that have together received 9.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (112 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (26 papers), Hematological disorders and diagnostics (23 papers), Acute Lymphoblastic Leukemia research (23 papers), Multiple Myeloma Research and Treatments (22 papers), Hematopoietic Stem Cell Transplantation (18 papers) and Lymphoma Diagnosis and Treatment (18 papers). The work is most often cited by research in Hematology (8.6k citations), Genetics (3.5k citations), Emergency Medicine (1.0k citations), Public Health, Environmental and Occupational Health (1.6k citations) and Orthopedics and Sports Medicine (453 citations). Carlo Aul has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Aristoteles Giagounidis, John M. Bennett, Pierre Fenaux, Ghulam Mufti, Guillermo Sanz, David Oscier, Christopher Cox, Michelle M. LeBeau, Teresa Vallespı́ and Pierre Morel. Their work appears in journals such as Blood, Leukemia Research, Annals of Hematology, British Journal of Haematology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact